Concepedia
Statistics
Publications
14
Citations
1.1K
H-Index
13
Active since
2007
Affiliations
University of Oxford(Current)
University of Edinburgh
University of Manchester
Centre for Inflammation Research
Genomics (United Kingdom)
Matthew Burgess is an author at University of Oxford specializing in life sciences, cell biology, and immunology.
Publications per year
2007–2024
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
Peter Schmid, Jacinta Abraham, Stephen Chan et al. · Journal of Clinical Oncology · 2019 · 389 citations · Full text
Medicine, Oncology, Pharmacology +16
Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer
Wade Nottingham, Andrew Jarratt, Matthew Burgess et al. · Blood · 2007 · 249 citations · Full text
Life Sciences, Developmental Biology, Molecular Genetics +14
Cx3CR1 Expression Identifies Distinct Macrophage Populations That Contribute Differentially to Inflammation and Repair
Matthew Burgess, Kate Wicks, Marina Gardasevic et al. · ImmunoHorizons · 2019 · 117 citations · Full text
Life Sciences, Cell Biology, Immunology +17
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics
Tom Quinn, Erin Gaughan, Annya Bruce et al. · EBioMedicine · 2022 · 53 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +11
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Gisella Figlioli, Massimo Bogliolo, Irene Catucci et al. · npj Breast Cancer · 2019 · 46 citations · Full text
Life Sciences, Genetics, Molecular Genetics +17
1–5 of 14